Skip to content
lifestyle.longislandreport.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Disc Medicine Inc
Disc Medicine to Participate in Upcoming Investor Conferences
September 2, 2026
Disc Medicine Announces Multiple Presentations Across Portfolio at the Society of Hematologic Oncology (SOHO) 2026 Annual Meeting
August 31, 2026
Disc Medicine Reports Second Quarter 2026 Financial Results and Provides Business Update
July 30, 2026
Disc Medicine Presents Positive Clinical Updates at the 2026 European Hematology Association (EHA) Annual Meeting
June 12, 2026
Disc Medicine Provides Update from FDA Type A Meeting for Bitopertin in Erythropoietic Protoporphyria
June 9, 2026
Disc Medicine Presents Updated Positive Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
June 2, 2026
Disc Medicine Launches Expanded Access Program for Bitopertin for EPP Patients
June 1, 2026
Disc Medicine Announces Oral Presentation of Data from RALLY-MF Phase 2 Trial of DISC-0974 in Patients with Myelofibrosis and Anemia at the American Society of Clinical Oncology (ASCO) Annual Meeting
April 21, 2026
Disc Medicine Receives Complete Response Letter from FDA for Bitopertin for the Treatment of EPP
February 14, 2026